**Core tip:** Pancreatic pseudocyst, the rare clinical entity poses a significant challenge in management given its rarity and lack of evidence suggesting the best managing approach. Most common procedures performed for those patients included open surgical drainage, laparoscopic drainage, radiology guided drainage, and endoscopic drainage. It remains unclear how different treatment modalities affect the outcome of patients with pancreatic pseudocyst. In the present study, we utilized the national inpatient sample to investigate the inpatient outcome of patients who underwent various procedures and provided practical information for clinicians.

INTRODUCTION
============

Pancreatic pseudocysts are defined as encapsulated, mature fluid collections that usually occur outside the pancreas, although they may be partly or entirely intrapancreatic. Pancreatic pseudocyst is one of the four types of pancreatic fluid collections, which also include acute peripancreatic fluid collection, acute necrotic collection and walled off necrosis and pancreatic pseudocyst according to Atlanta classification\[[@B1]\]. Pancreatic pseudocyst have a well-defined wall with minimal or no necrosis, making it different from the other three types of pancreatic fluid collection\[[@B2]\]. Pseudocysts are more commonly associated with acute pancreatitis or pancreatic trauma and typically form after four weeks since the initial insult\[[@B3]\]. However, they also occur in approximately 20%-40% patients with chronic pancreatitis\[[@B4]\]. Spontaneous resolution of pancreatic pseudocysts is not uncommon, therefore selected patients can be managed conservatively as watchful monitoring\[[@B5]\]. The most common indications for the decompression of the pseudocyst by include abdominal pain, nausea and vomiting, superimposed infection, or gastric outlet or biliary tract obstruction\[[@B6]\]. Treatment options include endoscopy-guided drainage, radiology-guided percutaneous drainage and surgical drainage with either laparoscopic or open surgical approach. However, the best methods for draining a pancreatic pseudocyst remains controversial. It was established historically that open surgery was the standard initial management for pancreatic pseudocysts, yet higher complication rates have been reported in previous studies\[[@B7]\]. With continued progression of medical technology, much less invasive options including laparoscopic, percutaneous and endoscopic drainage were increasingly reported. Previous study by Morton et al\[[@B8]\] in 2004 from NIS data from 1997 through 2001 using International Classification of Diseases (ICD)-9 diagnosis and procedure codes compared percutaneous with surgical drainage of pancreatic pseudocysts. The study showed that surgical approach is associated with shorter length of stay and decreased inpatient mortality, while percutaneous drainage had a higher rate of complications. However, the difference between laparoscopic approach and open surgical approach was not illustrated. With the advantage of ICD-10 codes, we are now able to differentiate the two different surgical modalities. Our study aim to examine population-based outcomes among different treatment options for pancreatic pseudocysts, namely, laparoscopic drainage, open surgical drainage and radiology-guided percutaneous drainage.

MATERIALS AND METHODS
=====================

Data source
-----------

The National Inpatient Sample (NIS) is an inpatient database maintained by the Agency for Healthcare Research and Quality (AHRQ). It updates annually the information on nearly 8 million inpatient stays from as many as around 1000 hospitals. The database represents a 20% sample of all hospital discharges in the United States, stratified by geographic region, size of the hospital, urban versus rural location, and teaching versus non-teaching status\[[@B9]\]. The data from this retrospective cohort study is obtained from 2016 National Inpatient Sample (NIS) and it represents of the entire population of the United States [Supplementary material](Supplementary material).

Study population
----------------

Cases of this study were discerned by ICD, Tenth Revision (ICD-10) diagnosis code for pancreatic pseudocyst, K863, and by procedure code 0F9G40Z, 0F9G4ZZ, 0F9G4ZX for laparoscopic drainage, codes 0F9G00Z, 0F9G0ZX, 0F9G0ZZ for open surgical drainage and codes 0F9G30Z, 0F9G3ZX, 0F9G3ZZ for radiology-guided percutaneous drainage of pancreatic pseudocysts. No specific ICD-10 procedure code was established for endoscopic drainage during the year 2016.

Patients with the age of greater than 18 years and with a status of non-pregnant were selected. Cases that had more than one of the above procedure codes were excluded, given the concern that if surgically drained patients have had prior percutaneous drainage, the adverse events may be overestimated from the previous percutaneous drainage, as illustrated by the previous study by Morton et al\[[@B8]\].

Patient characteristics and outcome variables
---------------------------------------------

Patient age, gender, race, admission type, hospital type, primary payer and comorbidities were examined. Charlson Comorbidity Index\[[@B10]\] (0-3, with 3 indicating greatest comorbidity) was calculated for each patient based on ICD-10 diagnosis codes, which permit risk stratification by a general severity of illness scale. Specific accompanying ICD-10 diagnosis codes included acute pancreatitis (K85x), chronic pancreatitis (K860, K861) and acute on chronic pancreatitis.

Patient outcomes after either laparoscopic drainage, open surgical drainage or percutaneous drainage were examined. We assessed outcomes including inpatient procedures, complication rates, length of stay (LOS), total charges, and inpatient mortality. Complications analyzed were pulmonary embolism, acute deep vein thrombosis, acute renal failure, urinary tract infection, pneumonia, sepsis, acute hepatic failure, acute respiratory failure, heart failure exacerbation, intraabdominal abscess and cardiac arrest. Inpatient procedures assessed were transfusion of red blood cell, fresh frozen plasma, platelet and mechanical ventilation.

Statistical analysis
--------------------

Chi-square analysis was used to compare procedure related adverse event rates and inpatient mortality. Mann-Whitney *U* test was used to compare length of stay among patient who received different procedures. Data analysis was performed using R programming software. *P* \< 0.05 was considered statistically significant.

RESULTS
=======

Demographics and comorbidities
------------------------------

A total of 7060 cases of pancreatic pseudocysts were identified in the NIS in 2016, including 702 patients who underwent drainage procedures. Of these, 248 (35.33%) patients underwent laparoscopic drainage, 107 (15.24%) with open surgical drainage and 347 (49.43%) patients with percutaneous drainage.

There is no significant difference of age distribution, gender or race among patients who underwent difference drainage procedures. No difference was noted about the pancreatitis type (acute *vs* chronic *vs* acute on chronic) among the three drainage methods (Table [1](#T1){ref-type="table"}). Neither Charlson Comorbidity Index nor specific comorbidities (Table [2](#T2){ref-type="table"}) was of statistically significant difference among patients receiving different drainages.

###### 

Baseline characteristics of the study cohort, *n* (%)

                               **Percutaneous**   **Laparoscopic**   **Open Surgical**   ***P* value**
  ---------------------------- ------------------ ------------------ ------------------- ---------------
  Age                                                                                    0.64
  18-35                        56 (16.1)          33 (13.3)          13 (12.1)           
  36-60                        175 (50.4)         137 (55.2)         55 (51.4)           
  60 +                         116 (33.4)         78 (31.5)          39 (36.4)           
  Sex                                                                                    0.15
  Male                         220 (63.4)         158 (63.7)         66 (61.7)           
  Female                       126 (36.3)         90 (36.3)          41 (38.3)           
  Race                                                                                   0.53
  White                        224 (64.6)         169 (68.1)         70 (65.4)           
  Black                        50 (14.4)          28 (11.3)          15 (14.0)           
  Hispanic                     39 (11.2)          20 (8.1)           14 (13.1)           
  Asian-Pacific Islander       9 (2.6)            3 (1.2)            2 (1.9)             
  Other                        14 (4.0)           13 (5.2)           2 (1.9)             
  Admission type                                                                         \< 0.001
  Emergency                    318 (53.4)         212 (35.6)         65 (10.9)           
  Non-emergency                26 (25.0)          36 (34.6)          42 (40.4)           
  Hospital type                                                                          \< 0.001
  Urban teaching               280 (47.6)         227 (38.6)         81 (13.8)           
  Urban non-teaching           58 (60.4)          19 (19.8)          19 (19.8)           
  Rural                        9 (50)             2 (11.1)           7 (38.9)            
  Primary payer                                                                          0.42
  Medicare                     111 (32.0)         62 (25.0)          35 (32.7)           
  Medicaid                     71 (20.5)          57 (23.0)          24 (22.4)           
  Private                      121 (34.9)         103 (41.5)         36 (33.6)           
  Other                        44 (12.7)          26 (10.5)          12 (11.2)           
  Pancreatitis type                                                                      0.06
  Acute                        164 (47.3)         89 (35.9)          35 (32.7)           
  Acute on chronic             84 (24.2)          71 (28.6)          25 (23.4)           
  Chronic                      38 (11.0)          36 (14.5)          17 (15.9)           
  Charlson Comorbidity index                                                             0.77
  0                            126 (36.3)         103 (41.5)         45 (42.1)           
  1-2                          189 (54.5)         123 (49.6)         56 (52.3)           
  3-4                          30 (8.6)           21 (8.5)           6 (5.6)             
  ≥ 5                          2 (0.6)            1 (0.4)            0 (0.0)             

###### 

Specific comorbidities of the study cohort, *n* (%)

                                          **Percutaneous**   **Laparoscopic**   **Surgical**   ***P* value**
  --------------------------------------- ------------------ ------------------ -------------- ---------------
  Acute myocardial infarction             15 (4.3)           8 (3.2)            5 (4.7)        0.74
  Congestive heart failure                31 (8.9)           19 (7.7)           4 (3.7)        0.21
  Peripheral vascular disease             15 (4.3)           7 (2.8)            3 (2.8)        0.56
  Cerebrovascular disease                 6 (1.7)            3 (1.2)            1 (0.9)        0.78
  Dementia                                2 (0.6)            3 (1.2)            0 (0.0)        0.42
  Chronic obstructive pulmonary disease   58 (16.7)          43 (17.3)          16 (15.0)      0.86
  Rheumatoid disease                      11 (3.2)           3 (1.2)            0 (0.0)        0.07
  Peptic ulcer disease                    10 (2.9)           13 (5.2)           3 (2.8)        0.28
  Mild liver disease                      52 (15.0)          36 (14.5)          9 (8.4)        0.21
  Diabetes without complications          105 (30.3)         61 (24.6)          32 (29.9)      0.29
  Diabetes with complications             12 (3.5)           11 (4.4)           5 (4.7)        0.77
  Hemiplegia or paraplegia                3 (0.9)            0 (0.0)            0 (0.0)        0.21
  Renal disease                           33 (9.5)           24 (9.7)           4 (3.7)        0.14
  Cancer (any malignancy)                 15 (4.3)           6 (2.4)            4 (3.7)        0.46
  Moderate or severe liver disease        10 (2.9)           17 (6.9)           7 (6.5)        0.06
  Metastatic solid tumour                 6 (1.7)            2 (0.8)            0 (0.0)        0.28
  AIDS/HIV                                2 (0.6)            1 (0.4)            0 (0.0)        0.72

Compared to patients with elective admission, those admitted through the emergency department are more likely to receive percutaneous drainage (53.4% *vs* 25.0%, risk ratio 2.04, 95%CI: 1.45-2.85). All types of hospital perform more percutaneous drainage (urban teaching 47.6%, urban non-teaching 60% and rural hospital 50%), yet rural hospitals perform more open surgical drainage (38.9%) (Table [1](#T1){ref-type="table"}).

Treatments and outcomes
-----------------------

Laparoscopic approach associated with the lowest rate of red blood cells transfusion (*P* \< 0.001), whereas percutaneous drainage had higher risk for acute renal failure (*P* = 0.01), urinary tract infection (*P* = 0.01), sepsis (*P* \< 0.001) and acute respiratory failure (*P* = 0.01) (Table [3](#T3){ref-type="table"}). Laparoscopic surgical approach associated with the shortest mean length of stay (7 d *vs* 11 d with open surgical approach *vs* 9 d of percutaneous drainage, *P* = 0.009). In patients discharged alive, those received laparoscopic drainage and surgical drainage are more likely to be discharged home (70.6% and 64.8%), compared to those received percutaneous drainage (49.4%, *P* \< 0.001). Laparoscopic drainage associated with the lowest total charge (121008 *vs* 165378 with open surgical *vs* 184240 with percutaneous drainage, *P* = 0.03). All three modalities have similar inpatient mortality (*P* = 0.28) (Table [4](#T4){ref-type="table"}). Multivariate analysis was performed which also demonstrated that laparoscopic drainage associated with shorter length of hospital stay (*P* = 0.001) and lower total charge (*P* = 0.017) comparing to non-laparoscopic drainage (Table [5](#T5){ref-type="table"}).

###### 

Procedure related complications, *n* (%)

  **Complications**               **Percutaneous**   **Laparoscopic**   **Open surgical**   ***P* value**
  ------------------------------- ------------------ ------------------ ------------------- ------------------------------------------
  Transfusion of RBC              39 (11.2)          7 (2.8)            20 (18.7)           \< 0.001[a](#T3FN1){ref-type="table-fn"}
  Transfusion of FFP              4 (1.2)            4 (1.6)            4 (3.7)             0.19
  Transfusion of Platelet         2 (0.6)            0 (0.0)            0 (0.0)             0.36
  Mechanical ventilation          37 (10.7)          18 (7.3)           12 (11.2)           0.31
  Pulmonary embolism              11 (3.2)           5 (2.0)            2 (1.9)             0.60
  Acute deep vein thrombosis      3 (0.9)            3 (1.2)            0 (0.0)             0.52
  Acute renal failure             84 (24.2)          49 (19.8)          12 (11.2)           0.01[a](#T3FN1){ref-type="table-fn"}
  Urinary tract infection         34 (9.8)           12 (4.8)           2 (1.9)             0.01[a](#T3FN1){ref-type="table-fn"}
  Pneumonia                       21 (6.1)           8 (3.2)            6 (5.6)             0.28
  Sepsis                          109 (31.4)         34 (13.7)          23 (21.5)           \< 0.001[a](#T3FN1){ref-type="table-fn"}
  Acute hepatic failure           5 (1.4)            6 (2.4)            1 (0.9)             0.53
  Acute respiratory failure       60 (17.3)          24 (9.7)           9 (8.4)             0.01[a](#T3FN1){ref-type="table-fn"}
  Exacerbation of heart failure   19 (5.5)           13 (5.2)           2 (1.9)             0.30
  Cardiac arrest                  5 (1.4)            3 (1.2)            0 (0.0)             0.47
  Intraabdominal abscess          34 (9.8)           14 (5.6)           8 (7.5)             0.18

*P* \< 0.05. RBC: Red blood cell; FFP: Fresh frozen plasma.

###### 

Inpatient outcome of the study cohort, *n* (%)

                           **Percutaneous**   **Laparoscopic**   **Surgical**   ***P* value**
  ------------------------ ------------------ ------------------ -------------- ------------------------------------------
  Length of stay, median   9                  7                  11             0.009[a](#T4FN1){ref-type="table-fn"}
  Total charge, mean       184240             121008             165378         0.03[a](#T4FN1){ref-type="table-fn"}
  Disposition, home        166 (49.4)         173 (70.6)         68 (64.8)      \< 0.001[a](#T4FN1){ref-type="table-fn"}
  Inpatient mortality      11 (3.2)           3 (1.2)            2 (1.9)        0.28

*P* \< 0.05.

###### 

Multivariable regression of length of stay and total charge

                                  **Standardized coefficient for length of stay**   ***P* value**   **Standardized coefficient for total charge**   ***P* value**
  ------------------------------- ------------------------------------------------- --------------- ----------------------------------------------- ---------------
  Type of pancreatitis                                                                                                                              
  Acute pancreatitis              Reference                                         Reference       Reference                                       Reference
  Chronic pancreatitis            -0.197                                            \< 0.001        -0.172                                          \< 0.001
  Acute on chronic pancreatitis   -0.130                                            \< 0.001        -0.148                                          0.001
  Hospital type                                                                                                                                     
  Urban teaching                  Reference                                         Reference       Reference                                       Reference
  Urban non-teaching              -0.054                                            0.19            0.009                                           0.82
  Rural                           -0.044                                            0.291           -0.046                                          0.277
  Drainage type                                                                                                                                     
  Laparoscopic                    Reference                                         Reference       Reference                                       Reference
  Non-laparoscopic                0.135                                             0.001           0.102                                           0.017

DISCUSSION
==========

This study compared different approaches for pancreatic pseudocyst drainage using a nationwide, population-based database. The NIS is a large, carefully designed database which provided an opportunity to investigate the in-hospital outcome of this rare yet not fully understood condition. With the advantage of ICD-10, we are the first study that is able to precisely define radiology guided percutaneous drainage and differentiate laparoscopic and open surgical approach. Despite similar clinical baseline, different treatment modalities are clearly associated with different complication profiles as well as clinical outcome. Our study provided practical information for clinicians when choosing a certain treatment modality for patients.

The study found that laparoscopic drainage of pancreatic pseudocysts associated with the least short-term complications comparing to percutaneous and open surgical drainage, including acute renal failure, urinary tract infection, sepsis and acute respiratory failure. While it was reported that surgical approach is associated with higher mortality and longer length of hospital stay, it remains unclear if the less invasive and more precise laparoscopic approach will provide clinical benefit compared to open approach. In this study, the mean length of stay of patients who underwent laparoscopic drainage was 4 d less than open surgical approach and 2 d less than percutaneous drainage. With the shorter length of stay, lower hospitalization cost, and least post-operative complications, we believe laparoscopic drainage is the most cost-effective modality among the three.

Percutaneous drainage is associated with the highest rate of developing acute respiratory failure and sepsis. It is possible that patients in this group had inadequate pseudocyst drainage leading to superimposed infection, causing prolonged sepsis. Likewise, percutaneous drainage is usually performed under sedation without endotracheal intubation and this predisposes patients to aspiration and pulmonary complications including acute respiratory failure. Moreover, comparing to laparoscopic drainage, patients receiving open surgical drainage are more prone to have acute blood loss during the surgery thus have a higher rate of red blood cell transfusion.

The study also demonstrates that patients with emergent admission received more percutaneous drainage followed by laparoscopic drainage. Controversies still exists regarding the best modality in emergent settings. Further studies need to be conducted to illustrate it. We also found that rural hospitals adhere to more traditional modality and performed more open surgical drainage. The drainage approach is not influenced by the type of pancreatitis, whether it is acute, chronic or acute on chronic. Also, Charlson Comorbidity Index and specific comorbidities are both similar among patients receiving different drainages, indicating that the difference in post-procedure complications is unlikely to be related to patients' underlying comorbidities.

Our study is limited by its retrospective nature and the limitation of ICD-10 in which the procedure code for endoscopic drainage is not established until 2017. Also, long term outcome is not available in the NIS database. Further studies especially randomized clinical trials should be conducted to determine the best treatment modality.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Current therapeutic techniques for pancreatic pseudocyst include surgical management with a laparoscopic approach or an open surgical procedure, percutaneous catheter drainage and endoscopic drainage.

Research motivation
-------------------

The best therapeutic technique for pancreatic pseudocyst remains controversial. We are motivated to investigate whether different treatment approaches affect inpatient outcome.

Research objectives
-------------------

The objectives of this study are to investigate inpatient outcome of different treatment approaches in treating pancreatic pseudocyst.

Research methods
----------------

Here we conducted a retrospective analysis of pancreatic pseudocyst-associated hospitalizations using the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample. International Classification of Diseases (ICD)-10 clinical modification and procedure codes are used.

Research results
----------------

A total of 7060 patients meeting the above criteria were identified. Our study revealed laparoscopic approach associated with the lowest rate of RBC transfusion (*P* \< 0.001), and it had lower short-term complications including acute renal failure (*P* = 0.01), urinary tract infection (*P* = 0.01), sepsis (*P* \< 0.001) and acute respiratory failure (*P* = 0.01). Laparoscopic surgical approach associated with the shortest mean length of stay (*P* = 0.009), and it had the lowest total charge (*P* = 0.03). All three modalities have similar inpatient mortality (*P* = 0.28). The study also revealed that percutaneous drainage associated with more emergent admission (*P* \< 0.001), rural hospital performs the most open surgical drainage (*P* \< 0.001) and patients who received laparoscopic drainage are more likely to be discharged home (*P* \< 0.001).

Research conclusions
--------------------

The study found that laparoscopic drainage of pancreatic pseudocysts associated with the least short-term complications and had better outcomes comparing to percutaneous and open surgical drainage from 2016 National Inpatient Sample (NIS) database. Laparoscopic surgical approach associated with the shortest mean length of stay. With the shorter length of stay, lower hospitalization cost, and least post-operative complications, we believe laparoscopic drainage is the most cost-effective modality among the three.

Research perspectives
---------------------

Our study is limited by its retrospective nature and the limitation of ICD-10 in which the procedure code for endoscopic drainage is not established until 2017. Also, long term outcome is not available in the NIS database. Further studies especially randomized clinical trials should be conducted to determine the best treatment modality.

Author contributions: Wang Y and Gong Z designed and performed analysis; Wang Y wrote the paper; Omar Y and Agrawal R made intellectual contributions to the completion of the research.

Institutional review board statement: The subject of this study is an open database (National Inpatient Sample). Therefore, the study is not considered as "research conducted on humans" and the statement is not applicable to our study.

Informed consent statement: The subject of this study is a public database (National Inpatient Sample). Therefore, the study is not considered as "research conducted on humans" and the statement is not applicable to our study.

Conflict-of-interest statement: The authors declare no conflicts of interest.

Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Manuscript source: Unsolicited manuscript

Peer-review started: July 14, 2019

First decision: August 2, 2019

Article in press: September 12, 2019

Specialty type: Gastroenterology and hepatology

Country of origin: United States

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): 0

Grade D (Fair): D

Grade E (Poor): 0

P-Reviewer: Mizuguchi T, Sperti C S-Editor: Ma RY L-Editor: A E-Editor: Zhou BX

[^1]: Corresponding author: Zimu Gong, MD, Doctor, Zimu Gong, Internal Medicine, AMITA Health St. Joseph Hospital, chicago 60657, IL, United States. <Zimu.Gong@amitahealth.org>

    Telephone: +1-773-6653000
